FDA — authorised 17 November 1993
- Application: BLA020168
- Marketing authorisation holder: GENENTECH
- Local brand name: NUTROPIN
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Nutropin on 17 November 1993
Yes. FDA authorised it on 17 November 1993; FDA authorised it on 9 March 1994.
GENENTECH holds the US marketing authorisation.